LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
5.46
-2.06 (-27.39%)
At close: Feb 21, 2025, 4:00 PM
5.51
+0.05 (0.90%)
After-hours: Feb 21, 2025, 7:45 PM EST
LifeMD Revenue
LifeMD had revenue of $53.39M in the quarter ending September 30, 2024, with 38.27% growth. This brings the company's revenue in the last twelve months to $193.06M, up 42.16% year-over-year. In the year 2023, LifeMD had annual revenue of $152.55M with 28.15% growth.
Revenue (ttm)
$193.06M
Revenue Growth
+42.16%
P/S Ratio
1.13
Revenue / Employee
$914,972
Employees
211
Market Cap
236.48M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
Dec 31, 2019 | 12.47M | 4.14M | 49.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
LFMD News
- 25 days ago - LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - GlobeNewsWire
- 2 months ago - LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 3 months ago - LifeMD, Inc. (LFMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - LifeMD Reports Third Quarter 2024 Results - GlobeNewsWire
- 5 months ago - LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 5 months ago - LifeMD: Selling WorkSimpli Could Be A Catalyst - Seeking Alpha
- 6 months ago - LifeMD to Participate in Three Investor Conferences During September - GlobeNewsWire
- 7 months ago - LifeMD, Inc. (LFMD) Q2 2024 Earnings Call Transcript - Seeking Alpha